Advertisement

Endocrine Evaluation of Hypospadias

  • Grace Hyun
  • Thomas F. Kolon
Conference paper
  • 299 Downloads
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 545)

Abstract

Hypospadias is a congenital defect of the penis resulting in an incomplete development of the anterior urethra (Duckett, 1998). The abnormal urethral opening may be any place along the shaft of the penis or open onto the scrotum or perineum. By the end of the first month of gestation, the hindgut reaches the surface of the embryo at the cloacal membrane on the ventral surface. The cloacal membrane is then divided by the urorectal septum into the anal and urogenital membrane. The genital tubercle and genital swellings appear around the urogenital membrane. A surge of luteinizing hormone from the pituitary gland leads to an increase of testosterone. Testosterone biosynthesis occurs at about 9 weeks gestation and hCG-LH receptors are present on fetal Leydig cells by at least 12 weeks of gestation. Androgens are critical for the induction, growth and differentiation of the genital tubercle into the male phenotype via the androgen receptor (AR), a nuclear transcription factor. Dihydrotestosterone, a metabolite of testosterone, mediates the action of androgens on the external genitalia and is known to bind to the AR with a higher affinity than testosterone. Masculinization of the external genitalia, namely elongation of the phallus, formation of the penile urethra from the urethral groove and development of the prepuce, depends on adequate testosterone synthesis, adequacy of the enzymatic pathway mediating the cascade and responsive end organs. During the third fetal month, the wolffian ducts complete their development and involution of the müllerian system occurs under the influence of müllerian inhibiting substance (MIS or AMH). A deficiency in the formation or delay in the maturation of the enzymes in the testosterone steroid cascade during these critical embryogenesis periods may be responsible for incomplete development.

Keywords

External Genitalia Androgen Receptor Expression Wolffian Duct Hydroxysteroid Dehydrogenase Androgen Insensitivity Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aaronson, I.A., Cakmak, M.A., Key, L.L., 1997, Defects of the testosterone biosynthetic pathway in boys with hypospadias.J Uro1,157(5):1884–1888. CrossRefGoogle Scholar
  2. Aarskog D., 1979, Current concepts: maternal progestins as a possible cause of hypospadias.N Engl J Med300:75–78.PubMedCrossRefGoogle Scholar
  3. Allen, T.D. and Griffin, J.E., 1984, Endocrine studies in patients with advanced hypospadias.J Urol131:310–314.PubMedGoogle Scholar
  4. Allera, A., Herbst, M.A., Griffin, J.E. et al., 1995, Mutations of the AR gene coding sequence are infrequent in patients with isolated hypospadias.J Clin Endocrinol Metab80:2697–9.PubMedCrossRefGoogle Scholar
  5. Andersson S., 1995, 17 beta hydroxysteroid dehydrogenase: isozymes and mutations.J Endocrinol146:197–200.PubMedCrossRefGoogle Scholar
  6. Angerpointer T., 1984, Hypospadias- Genetics, epidemiology and other possible aetiological influences.Z Kinderchir39:112–118. Google Scholar
  7. Austin, P.F., Siow, Y., Fallat, M.E., et al., 2002, The Relationship Between Müllerian Inhibiting Substance and Androgens in Boys with Hypospadias.J Urol168:1784–1788. PubMedCrossRefGoogle Scholar
  8. Bauer, S.B., Retik, A.B., and Colodny, A.H., 1981, Genetic aspects of hypospadias.Urol Clin North Am8:559564.Google Scholar
  9. Bjerkedal, T. and Bakketeig, L.S., 1975, Surveillance of congenital malformations and other conditions of the new born.In J Epidemiol4:31–36.CrossRefGoogle Scholar
  10. Calzolari, E., Contrero, M.R., Roncarati, E., et al., 1986, Aetiological factors in hypospadias.J Med Genet23:333–337. PubMedCrossRefGoogle Scholar
  11. Can, S., Zhu,Y-S, Cai, L-Q, et al., 1998, The identification of 5_ reductase 2 and 17_ hydroxysteroid dehydrogenase 3 gene defects in male pseudohermaphrodites from a Turkish kindred.J Clin Endocrino! Metab83:560–569. CrossRefGoogle Scholar
  12. Casella, R., Kolon,T.F., Maduro, M., et al., CAG repeat length in exon 1 of the androgen receptor gene of patients with cryptorchidism and/or hypospadias. Presented at annual meeting of Section on Urology, American Academy of Pediatrics, San Francisco, California, October 20–22, 2001.Google Scholar
  13. Castro-Magana, M., Angulo, M., and Uly, J., 1993, Male hypogonadism with gynecomastia caused by late-onset deficiency of testicular 17-ketosteroid reductase.N Engl J Med328:1297–1301. PubMedCrossRefGoogle Scholar
  14. Clark, R., Antonello, J., Grossman, S., et al., 1990, External genitalia abnormalities in male rats exposed in utero to finasteride, a 5a reductase inhibitor.Teratology;42:91–100.PubMedCrossRefGoogle Scholar
  15. Clark, R., Antonello, J., Grossman, S., et al., 1993, Critical developmental periods for effects on male rat genitalia induced by finasteride, a 5a reductase inhibitor.Toxicol Appl Pharmacol119:34–40. PubMedCrossRefGoogle Scholar
  16. Czeizel, A., Toth, J. and Erodi, E., 1979, Aetiological studies of hypospadias in Hungary.Hum Hered38:45–50. Google Scholar
  17. Czeizel, A., 1985, Increasing trends in congenital malformations of male external genitalia.Lancet1:462–463.PubMedCrossRefGoogle Scholar
  18. Dean, H.J. and Winter, J.S., 1984, The effect of five synthetic progestational compounds on 5 alpha reductase activity in genital skin fibroblast monolaYERS.Steroids43:13–17. PubMedCrossRefGoogle Scholar
  19. Dolk, H., 1998, Rise in the prevalence of hypospadias.Lancet351:770.PubMedCrossRefGoogle Scholar
  20. Duckett, J.W., 1998, Hypospadias. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ, eds. Campbell’s Urology, 7`sed. Philadelphia, PA: W. B. Saunders Co., vol. 2, chapt. 68,2093–2119Google Scholar
  21. Feyaerts, A., Forest, M.G., Morel,Y., et al., 2002, Endocrine Screening in 32 Consecutive Patients with Hypospadias.J Urol168:720–725.PubMedCrossRefGoogle Scholar
  22. Fredell, L., Iselius,L., Collins, A. et al., 2002, Complex segregation analysis of hypospadias.Hum Genet111:231–234. PubMedCrossRefGoogle Scholar
  23. Gearhart, J.P., Linhard, H. R., Berkovitz, G.D. et al., 1988, Androgen receptor levels and 5 alpha-reductase activities in preputial skin and chordee tissue of boys with isolated hypospadias.J Urol 140(5 pt 2):1243-1246.Google Scholar
  24. Geissler, W.M., Davis, D.L., Wu,L., et al., 1994, Male pseudohermaphroditism caused by mutations of testicular 17 beta hydroxysteroid dehydrogenase3.Nat Genet7:34–39.PubMedCrossRefGoogle Scholar
  25. Griffin, J. and Wilson, J. The androgen resistance syndromes: 5a reductase deficiency, testicular feminization and related disorders. In The metabolic Basis of Inherited Disease, C Scriver, A Beaudet, W Sly, D Valle, eds., 6’hEd., Vol II, McGraw-Hill, NY, 1989: 1919–1944.Google Scholar
  26. Goldman, A.S. and Bongiovanni, A.M.., 1967, Induced genital anomalies. Ann NYAcad Sci, 142:755–767.CrossRefGoogle Scholar
  27. Hakimi, J.M., Rondinelli, R.H., Schenberg, M.P., et al., 1996, Androgen receptor gene structure and function in prostate cancer.World J Urol14:329–337.PubMedCrossRefGoogle Scholar
  28. Hiort, O., Willenbring, H., Albers, N., et al., 1996, Molecular genetic analysis and human chorionic gonadotropin stimulation tests in the diagnosis of prepubertal patients with partial 5 alpha reductase deficiency.Eur j Pediatr155:445–451.PubMedCrossRefGoogle Scholar
  29. Holmes, N.M., Miller, W.L. and Baskin, L.S., Defects in androgen production as a role in the etiology of hypospadias. Presented at annual meeting of Section on Urology, American Academy of Pediatrics, San Francisco, California, October 20–22, 2001.Google Scholar
  30. Imperato-McGinley,J., Miller, M., Wilson, J., et al., 1991, A cluster of male pseudohermaphrodites with 5a reductase deficiency in Papua New Guinea.Clin Endocrinol34:293–298.CrossRefGoogle Scholar
  31. Kallen, B. and Winberg, J., 1982, An epidemiological study of hypospadias in Sweden.Acta Paediatr Scand Suppl293:3–21. Google Scholar
  32. Kallen, B., Bertolini, R., Castilla, A., et al., 1986, A joint international study on the epidemiology of hypospadias.Acta Paediatr Scand Suppl,324:1–52. PubMedCrossRefGoogle Scholar
  33. Kim, K.S., Liu,W., Cunha, G.R., et al., 2002, Cell Tissue Res., 307(2):145–53.Epub2001 Nov 27.Google Scholar
  34. Knorr, D., 1979, Plasma testosteronein malepuberty. II. hCG stimulation testinboys with hypospadias.Acta Endocrino!(Copenh), 90:365.Google Scholar
  35. Kohn, G., Lasch, E.E., El-Shawwa, R., et al., 1985, Male pseudohermaphroditism due to 17-beta hydroxysteroid dehydrogenase deficiency in a large Arab kinship: studies on the natural history of the defect.J Pediatr Endocr1:29–37.CrossRefGoogle Scholar
  36. Kolon, T.F., Murthy, L., Gonzales, E.T., Jr., et al., Prevalence of intersex in hypospadias and cryptorchidism. Presented at annual meeting of Section on Urology, American Academy of Pediatrics, San Francisco, California, October 20–22, 2001.Google Scholar
  37. MacLean, H.E., Warne, G.L., and Zajac, J.D., 1995, Defects of androgen receptor function: from sex reversal to motor neurone disease.Molec Cell Endocrinol112:133–141. PubMedCrossRefGoogle Scholar
  38. Matlai, P. and Beral, V., 1985, Trends in congenital malformations of external genitalia.Lancet1:108. Mau, G., 1981, Progestins during pregnancy and hypospadias.Teratology24:285–287.Google Scholar
  39. Monteleone, N.R., Castilla, E.F. and Paz, J.E., 1981, Hypospadias: An epidemiologic study in Latin America.Am J Med Genet10:5–19.CrossRefGoogle Scholar
  40. Nonomura, K., Fujieda, K., Sakakibara, N. et al., 1984, Pituitary and gonadal function in prepubertal boys with hypospadias.J Urol132:595–598.PubMedGoogle Scholar
  41. North, K. and Golding, J., 2000, A maternal vegetarian diet in pregnancy is associated with hypospadias. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood.BJUInt.85(1):107–13. CrossRefGoogle Scholar
  42. Paulozzi, L.J., Erickson, D.J., and Jackson, R.J., 1997, Hypospadias trends in two American surveillance systems.Pediatrics100:831–834.PubMedCrossRefGoogle Scholar
  43. Prahalada, S., Tarantal, A.F., Harris, G.S., et al., 1997, Effects of finasteride, a type 2 5-alpha reductase inhibitor, on fetal development in the rhesus monkey (Macaca mulatta).Teratology. Feb 55(2):119–31. CrossRefGoogle Scholar
  44. Raman-Wilms, L., Tseng, A., Wighardt, S., et al., 1995, Fetal genital effects of first tri85 imester sex hormone exposure: a meta-analysis.Obstet Gynecol141–149.Google Scholar
  45. Rosier, A., 1992, Steroid 17 beta hydroxysteroid dehydrogenase in man: an inherited form of male pseudohermaphroditism.JSteroid Biochem MolBiol,43:989–1002.CrossRefGoogle Scholar
  46. Russell, D.W. and Wilson, J.D., 1994, Steroid 5 alpha reductase: two genes/two enzymes.Ann Rev Biochem63:25–61.PubMedCrossRefGoogle Scholar
  47. Shima, H., Ikoma, F., Yabumoto, H., et al., 1986, Gonadotropin and testosterone response in prepubertal boys with hypospadias.J Urol135:539–542.PubMedGoogle Scholar
  48. Shima, H., Yabumoto, H., Okamoto, E., et al., 1992, Testicular function in patients with hypospadias associated with enlarged prostatic utricle.Br J Urol69:192–195.PubMedCrossRefGoogle Scholar
  49. Siiteri, P. and Wilson, J., 1974, Testosterone formation and metabolism during male sexual differentiation in the human embryo.J Clin Endocrinol Metab38:113–124.PubMedCrossRefGoogle Scholar
  50. Silver, R.I. and Russell, D.W., 1999, 5-reductase type 2 mutations are present in some boys with isolated hypospadias.J Urol162:1142–1145.PubMedCrossRefGoogle Scholar
  51. Silver, R.I., Rodriguez,R., Chang, T.S., et al., 1999, In vitro fertilization is associated with an increased risk of hypospadias.J Urol161:1954–1957.PubMedCrossRefGoogle Scholar
  52. Sinnecker, G.H., Hiort, O., Dibbelt, L., et al., 1996, Phenotypic classification of male pseudohermaphroditism due to steroid 5 alpha reductase 2 deficiency.Am J Med Genet63:223–230,PubMedCrossRefGoogle Scholar
  53. Sorenson, H.R. 1953, Hypospadias with special reference to aetiology. CopenhagenMunksgaard94.Google Scholar
  54. Sutherland, R.W., Weiner, J.S., Hicks, J.P., et al., 1996, Androgen receptor gene mutations are rarely associated with isolated penile hypospadias.J Urol156:828–831.Google Scholar
  55. Sweet, Ra, Schrott, H.G., Kurland, R., et al., 1974, Study of the incidence of hypospadias in Rochester, Minnesota 1940–1970 and a case control comparison of possible etiologic factors.Mayo Clin Proc49:52–57.Google Scholar
  56. Thigpen, A., Davis, D., and Milatovich, A., 1992, Molecular genetics of steroid 5 alpha reductase deficiency.J Clin Invest90:799–809.PubMedCrossRefGoogle Scholar
  57. Thigpen, A., Silver,R., Guileyardo, J., et al., 1993, Tissue distribution and ontogeny of steroid 5 alpha reductase isozyme expression.J Clin Invest92:903–910.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2004

Authors and Affiliations

  • Grace Hyun
    • 1
  • Thomas F. Kolon
    • 1
    • 2
  1. 1.Division of Urology The Children’s Hospital of Philadelphia Department of UrologyUniversity of Pennsylvania School of MedicineUSA
  2. 2.The Children’s Hospital of PhiladelphiaPhiladelphia

Personalised recommendations